D&D Pharmatech secures Japanese patent for TLY012 liver fibrosis drug
AI Summary- D&D Pharmatech secured Japanese substance-patent registration for TLY012.
- TLY012 rights now cover Japan, the United States, Australia and China.
- D&D Pharmatech plans global liver-fibrosis trials as early as next year.